# FDA recall D-0218-2017

> **Hospira Inc., A Pfizer Company** · Class I · drug recall initiated 2016-08-04.

## Product

Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1159-02

## Reason for recall

Presence of particulate matter: Confirmed customer report for the presence of particulate matter within a single vial.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-0218-2017
- **Recalling firm:** Hospira Inc., A Pfizer Company
- **Classification:** Class I
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2016-08-04
- **Report date:** 2016-12-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Lake Forest, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0218-2017

## Citation

> AI Analytics. FDA recall D-0218-2017. Retrieved 2026-07-16 from https://api.ai-analytics.org/recall/D-0218-2017. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*